Here are five things to know.
1. C. auris is a drug-resistant yeast causing infections in healthcare settings around the globe. Some strains of the fungus are resistant to all three classes of antifungal medications. The fungus can cause serious bloodstream and wound infections.
2. The drug-resistant yeast was first identified in Japan in 2009 and spread to the U.K. in 2013.
3. As of July, more than 200 patients have been infected with C. auris at 20 separate National Health Services trusts and independent hospitals, according to the BBC.
4. Large outbreaks occurred at three U.K. hospitals since 2013, but have since ended. During one such outbreak at Royal Brompton Hospital in London, 50 patients were infected from April 2015 to July 2016.
As of July 14, the CDC has identified 98 C. auris infections among U.S. residents and detected colonization with the fungus in 110 patients.
More articles on infection control:
Top 10 infection control stories, Aug. 7-11
Rotavirus vaccinations saved the US at least $1.2B in medical costs, study shows
300+ sickened in Ohio norovirus outbreak
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.